PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Am J Emerg Med. Author manuscript; available in PMC 2012 July 1.
Published in final edited form as:
PMCID: PMC3005542
NIHMSID: NIHMS201247

Urgent Neurology Consultation from the Emergency Department for Transient Ischemic Attack

1. Introduction

Transient ischemic attack (TIA) is common with well over 300,000 Emergency Department (ED) visits for TIA in the United States each year.1 The ED management for this common presentation is particularly challenging because TIA symptoms are by definition evanescent in nature, which makes them difficult for patients to describe, and because TIA symptoms can mimic diverse alternate diagnoses such as migraine or seizure, which makes the diagnosis more complex. Furthermore, the stakes for making an accurate diagnosis are high because there has been a growing appreciation that the early risk of stroke after TIA is high,2 and that urgent evaluation and intervention may be effective at reducing this risk.3,4 Therefore, developing efficient and effective processes of care for ED patients with TIA has been a major goal for emergency medicine and stroke neurology.

Various models of care such as routine inpatient admission,5 Emergency Department observation units,6 or expedited outpatient follow-up clinics with stroke specialists3,4 have been proposed to help address this need but significant practice variation remains.7 Within this context, the potential role of urgent neurology consultation in the ED has received relatively less attention. Instead, previous studies have focused on the impact of consultation for ED patients generally10, or a neurologist’s role within a stroke center or stroke network specifically,11 or on the outcomes of inpatients with stroke who are under the care of a neurologist rather than an internist.12-17 Less is known about the impact of urgent neurology consultation in the emergency department (ED) for patients with TIA. Since the availability of neurologists for urgent consultation is often constrained and since the value-added by an urgent neurology consultation is unknown,8, 9 better information on the impact of neurology consultation on process measures and outcomes is required for policymakers and clinicians to make rational decisions on how to optimize the care for these patients.

Therefore, we conducted a secondary data analysis of a cohort of ED patients diagnosed with TIA to examine associations between neurology consultation and process and outcome measures. Our goals were 1) to examine the factors that were associated with urgent neurology consultation for TIA; 2) to examine the association between neurology consultation and process improvements such as increased use of antithrombotic agents (aspirin, clopidogrel, ticlopidine, heparin, or warfarin), increased use of neuroimaging, increased utilization of anticoagulation for atrial fibrillation; and 3) to examine the association of these process improvements on clinical outcomes as measured by the number of strokes and major adverse events within 90 days of presentation.

2. Methods

We performed a secondary analysis of data from a cohort of patients diagnosed with TIA in the ED from March 1997 to May 1998 within a large managed care plan.2 Briefly, patients were identified from a database of ED encounters at 16 Northern California EDs (Sacramento, Santa Rosa, and San Francisco Bay Area) within the Kaiser-Permanente Medical Care (KPMC) system, an integrated health care program. The three million members of KPMC are widely representative of the population of the Northern California region as a whole.18 All of the EDs included in this study had 24-hour coverage by an on-call neurologist by telephone and for in-person consultation if necessary. Local institutional review boards approved the data collection, abstraction, and data handling procedures for this study.

Patients were identified by a database search of a comprehensive ED visit database for the primary diagnosis of transient ischemic attack. Patients who were not KPMC members, who did not have ED records, who had miscoded diagnoses, or who had a prior TIA during the study period were excluded.2

Demographic and clinical data were abstracted from ED charts, medical records, and clinical databases as previously described.2 Briefly, a trained data abstractor blinded to the present analysis abstracted data from clinical databases and medical records with a standardized chart abstraction form. A neurology consultation was defined as any contact by the ED clinicians with an on-call neurologist whether in person or by telephone. An electronic system for imaging reports became available in November 1997, so analysis of the use of neuroimaging was limited to the subgroup of all patients who were seen after than date (n=453).

Patients were followed for 90 days after presentation. Subsequent strokes, TIAs, major cardiovascular events (hospitalization for ventricular arrhythmia, myocardial infarction, congestive heart failure, or unstable angina), and death were identified using a database search of in-network hospitalization and claims records for out-of-network hospitalizations that allowed for near complete ascertainment of outcomes and near complete follow up. Outcomes were adjudicated by independent confirmation by two neurologists who were blinded to the present analysis as previously described.2

Fisher’s exact test was used to evaluate univariate associations. A two-sample Wilcoxon rank-sum test was used to compare the median ABCD2 score in the consultation and no consultation groups. The ABCD2 score is a validated prediction tool that uses five factors to estimate the short-term stroke risk after TIA: age ≥ 60 years (1 point); blood pressure ≥ 140/90 mmHg (1); clinical features of unilateral weakness (2) or speech impairment without weakness (1); duration ≥ 60 minutes (2) or 10-59 minutes (1); and diabetes (1).19 Multivariable analysis was performed using generalized estimating equations to account for clustering by facility and using the raw ABCD2 score to adjust for the baseline risk of stroke for each patient.. The cumulative incidence of stroke and major adverse events was estimated using survival analysis with censoring of patients at death, carotid endarterectomy, or loss to follow-up. The log-rank test was used for comparisons between groups. All data were analyzed using the Stata statistical package (version 9, StataCorp, College Station, Texas).

3. Results

Frequency of Neurology Consultation

In this cohort from 1997-8, an in-person or telephone consultation with a neurologist was obtained for 474 (28%) of the 1,707 patients. Most (414 or 87%) of these neurology consultations were by telephone only; 60 patients were evaluated by a neurologist in-person while in the ED. Consultation rates varied from 6.2% to 44.9% among the 16 facilities studied. Patients who presented to the ED between 8 a.m. and 5 p.m. on non-holiday weekdays were more likely to have a neurology consultation than those who were evaluated after-hours, on weekends, or on holidays (31% vs. 26%, p=0.03).

Demographic Characteristics, Risk Factors, and Clinical Presentation

Median age was comparable in the consultation and no consultation groups (Table 1). Blacks were less likely to have a neurology consultation; 20% of black TIA patients had a neurology consultation compared with 29% of white TIA patients (p=0.01). There was significant variation in proportion of TIA patients who were black (range 2% to 37%) and the proportion of TIA patients who had a consultation (range 6% to 45%) by site. A quarter (25%) of male TIA patients had a neurology consultation compared to 31% of female TIA patients (p<0.01). Vascular risk factors were common overall; hypercholesterolemia was more common in the consultation group (18% vs. 13%, p=0.01). Consultation patients were more likely to be already taking aspirin at presentation (41% vs. 30%, p<0.001).

TABLE 1
Characteristics of Patients with TIA at Presentation to the ED

We compared baseline history and examination findings as an exploratory analysis of factors that might predict consultation status. Patients with sensory symptoms and vision changes were more likely to have a consultation and patients with a history of confusion were less likely to have a neurology consultation. Consultation patients were more likely to have weakness by exam or symptoms that were still present at presentation to the ED. The presence of a carotid bruit was associated with neurology consultation although the presence or absence of a bruit was documented for only 53% of patients. However, some factors included in the ABCD2 score (such as symptoms lasting more than 10 minutes, changes in speech, report of weakness, vertigo, or gait difficulties) were not associated with consultation (Table 1).

The median ABCD2 score was similar for patients who had a neurology consultation (median ABCD2 score = 4) and patients who did not (Wilcoxon rank-sum p=0.72; Figure 1).

Hospital Admissions, Utilization of Diagnostic Tests, and Medications

After excluding patients who had a stroke in the ED prior to hospital admission, patients who had a neurology consultation were more likely to be admitted to the hospital (18% vs. 14%, OR 1.36 [1.01-1.81], p=0.04). This association persisted even after adjustment for ABCD2 score and for clustering by facility (adjusted OR=1.35, 95% CI 1.02-1.78, p=0.04). The overall use of diagnostic tests was similar in the two groups (Table 2). For example, electrocardiograms (ECG) and echocardiograms were obtained in a similar proportion of patients in the two groups.

TABLE 2
Utilization of Diagnostic Studies

Data on neuroimaging studies was only available for all patients seen after November 1997 when an electronic imaging reports system became available (n=453). For this subgroup, a similar proportion of patients had head computed tomography (CT) or brain magnetic resonance (MR) imaging within the first 48 to 72 hours. Finally, the proportion of patients who had carotid ultrasounds within one week was also similar in the consult and no consult groups (Table 2).

Patients with neurology consultation were more likely discharged on antithrombotic therapy (92% vs. 87%, OR 1.91 [1.22-2.98], p=0.004). This association persisted after adjusting for ABCD2 score and clustering by facility (adjusted OR=1.87, [1.22-2.87], p=0.004). Among the subgroup of patients who were not already taking antithrombotics at the time of presentation (n=951), consultation patients were still more likely to be placed on antithrombotic therapy than those who were not evaluated by neurologists (89% vs. 84%, OR 1.60 (1.01-2.54), p=0.04; adjusted OR 1.58 (1.04-2.40), p=0.03).

For the subgroup of patients with a previous history of atrial fibrillation or with new atrial fibrillation diagnosed on electrocardiogram (n=179), the percentage of patients discharged on anticoagulation (46% vs. 48% in the no consult group, p=1.00) or on any antithrombotic therapy (88% vs. 89% in the no consult group, p=0.78) was comparable.

Stroke, Major Cardiovascular Events, and Adverse Outcomes

At one week, the probability of stroke-free survival and of adverse-event free survival (stroke, major cardiovascular events, or death) was lower with neurology consultation (5.3% vs. 7.5%, p=0.01; and 5.3% vs. 7.8%, p=0.02 respectively). But at 90 days the magnitude of this difference was smaller and was not statistically significant (9.9% vs. 11.0% for stroke, p=0.41; 11.6% vs. 13.6% for adverse events, p=0.48; Figure 2).

4. Discussion

In this cohort drawn from a large integrated health care program in 1997-8, neurology consultation for TIA was uncommon overall (28%) and in-person consultation was rare (4% overall). Previous studies that captured only in-person consultations rather than telephone consultations and have reported rates ranging from 8% in a cohort of TIA and stroke patients in an urban ED20 to 29% of TIA patients in a rural ED that would otherwise be considered neurologically underserved.21 Our analysis reflects practice patterns that existed before the risks of stroke after TIA were more widely appreciated, but more recent data reflecting current practice for consultation for TIA has not been widely reported.

The decision to consult a neurologist from the ED is a complex one. We did find that patients who were at higher risk for stroke were not the ones who were targeted for urgent neurological evaluation; indeed there was no relationship between a higher risk of stroke as predicted by the ABCD2 score and more frequent urgent neurology consultation. This finding underscores the potential value of this prognostic tool to help guide clinical decision-making in current practice because reliable and validated methods for identifying high-risk TIA patients were not available during the study period.

Instead, the decision about whether to obtain a neurology consultation from the ED appeared to rely on other factors that were independent of risk. Such factors may include institutional norms and local practice patterns, the availability of an on-call neurologist, and the perceived value-added by a consultation in the acute setting. Other factors might include clinical uncertainty rather than acuity since patients who were perceived to be low-risk, but where the diagnosis was uncertain may have targeted for consultation (e.g. patients with migraine on the differential diagnosis). But our cohort was limited to only those patients who had a final ED diagnosis of TIA. Alternatively, certain higher-risk patients may have been targeted for consultation only if management was uncertain. For instance, patients who were already taking aspirin were more likely to have consultations (e.g. patients having possible vascular events while on antiplatelet therapy [“aspirin-failures”]). ED clinicians could have been seeking advice on alternative antithrombotic therapy for these patients. The racial and sex disparities in consultation requests that we observed were more difficult to explain, though they parallel previously described disparities in referral patterns and inpatient treatment of TIA22 and for stroke23, 24 and merit further study. These comparisons of baseline characteristics by consultation status are exploratory in nature and may represent hypotheses for future study.

Given the lack of a clear association between patient acuity and consultation, it is not unexpected that we found only weak associations between consultation and improved process of care measures for TIA. The main areas of associated improvements were in more frequent use of antiplatelet and anticoagulation therapy and in higher rates of hospital admission, both of which have the potential to impact patient outcomes. Our study is unable to distinguish between whether the decision to prescribe antithrombotics or to admit the patient was made prior to consultation or as a consequence of consultation. But these associations did not appear to be simply a marker for more intensive management for consultation patients generally. Although utilization of diagnostic testing for patients with TIA overall may be different today, we found no clear association between consultation and the use of brain imaging, ECGs, and carotid ultrasound, or on the use of anticoagulation for cases of atrial fibrillation, which was comparable to nationally reported rates.26 To the extent that utilization of diagnostic testing is a process measure that may be important for improvement in outcomes, this finding would be expected to attenuate any observed differences in outcomes by consultation status.

Previous studies examining the impact of neurologists have largely focused on stroke rather than TIA. Here the evidence has been conflicting. Some studies have suggested that timely neurological attention is associated with better outcomes13-17 and shorter hospitalizations.25 However, a more recent analysis that accounted for differences in the initial prognosis for patients treated by neurologists versus internists has brought some of these conclusions into question.12 These studies highlight the difficulty of identifying an independent effect of neurologists on clinical outcomes within the milieu of heterogeneous practice patterns.

Given that the ABCD2 score was similar in the two groups, one would expect that the observed incidence of subsequent stroke would also be similar. In fact we found that during the first week, when the risk for stroke after TIA is highest, the probability of stroke and of adverse outcomes was lower for consultation patients. But by 90 days, although we observed a 1.1% lower absolute incidence of stroke and a 2% lower absolute incidence of adverse events with consultation, the overall magnitude of this difference was smaller as compared to the initial period and did not meet statistical significance. The heterogeneous nature of neurology consultation, particularly during the study period when there was less consensus on optimal management, as well as the additional impacts of subsequent inpatient and outpatient management decisions would both serve to dilute the potential impact of consultation on longer-term outcomes.

Several limitations of our study are important to consider in interpreting these findings. First, consultations were obtained in the period before the urgent risks of TIA were widely appreciated and before there was a greater consensus on optimal management of TIA. Also practice patterns in a large integrated health care program may not reflect current practice in other clinical settings. Both of these factors limit generalizability to current practice. Second, since our analysis was focused only on urgent neurology consultations from the ED, in-patient neurology consultations that took place after hospital admission or in follow-up were not captured. This effective “crossover” of patients from the no consultation to the consultation group could lead to an underestimation of the impact of consultation and could explain the discrepancy between the one-week and the 90-day outcomes that was observed. Third, important prognostic differences between the two groups that influenced the decision on consultation may not have been captured, particularly since patients who had a neurology consultation and were not given the final diagnosis of TIA would not be captured in our cohort. The important potential role of neurologists in helping to identify patients who did not have a TIA cannot be addressed with the current study. Potential for confounding by indication akin to that encountered in similar studies of stroke patients is possible as well,12 though we attempted to mitigate the effects of prognostic differences in the groups by using the validated ABCD2 score. Nonetheless, other unmeasured confounders may limit the validity of inferences drawn from our analysis. Fourth, the specific content of the consultation and the changes in management that are directly attributable to the neurology consultation was not available. Finally, as a secondary analysis and an observational study, multiple comparisons and subgroup analysis may limit interpretation of our findings beyond hypothesis-generating exploratory analysis.

In summary, we found that during a period before the widespread appreciation of the risks of stroke after TIA, urgent neurology consultation was not targeted to patients who were at highest-risk for stroke. Although we found that urgent neurology consultation was associated with modest improvements early patient outcomes, these associations did not persist at 90 days. Here we present a snapshot and exploratory analysis of previous practice patterns that may form the basis for comparisons to current practice and may serve to highlight the importance of determining the particular processes of care that have the most impact on clinical outcomes. Current practice in terms of diagnostic testing, neurology consultation, and use of antithrombotic medications is likely to have changed and it is possible that neurology consultation may be more valuable today with a greater consensus on the optimal acute management of TIA,27-29 a greater recognition of the impact of aggressive early interventions,3,4 and an emphasis on developing specific quality measures by health care funding agencies, accreditation organizations, and professional groups.30

TABLE 3
Treatment and Disposition

Acknowledgments

Sources of Support: This work was supported by the National Institute for Neurological Disorders and Stroke (K08NS002042). This work was also supported by an award from the American Heart Association.

Footnotes

Presented at the American Academy of Neurology Annual Meeting, Boston, MA, May 2007.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

[1] Edlow JA, Kim S, Pelletier AJ, Camargo CA. National study on emergency department visits for transient ischemic attack, 1992-2001. Acad Emerg Med. 2006;13:666–72. [PubMed]
[2] Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901–6. [PubMed]
[3] Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370:1432–42. [PubMed]
[4] Lavallée PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6:953–60. [PubMed]
[5] Nguyen-Huynh MN, Johnston SC. Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology. 2005;65:1799–801. [PubMed]
[6] Stead LG, Bellolio MF, Suravaram S, et al. Evaluation of transient ischemic attack in an emergency department observation unit. Neurocrit Care. 2009;10:204–8. [PubMed]
[7] Chang E, Holroyd BR, Kochanski P, Kelly KD, Shuaib A, Rowe BH. Adherence to practice guidelines for transient ischemic attacks in an emergency department. Can J Neurol Sci. 2002;29:358–63. [PubMed]
[8] Josephson SA, Engstrom JW, Wachter RM. Neurohospitalists: an emerging model for inpatient neurological care. Ann Neurol. 2008;63:135–40. [PubMed]
[9] Carroll C, Zajicek J. Provision of 24 hour acute neurology care by neurologists: manpower requirements in the UK. J Neurol Neurosurg Psychiatry. 2004;75:406–9. [PMC free article] [PubMed]
[10] Moulin T, Sablot D, Vidry E, et al. Impact of emergency room neurologists on patient management and outcome. Eur Neurol. 2003;50:207–14. [PubMed]
[11] Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597–616. [PubMed]
[12] Gillum LA, Johnston SC. Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med. 2008;3:184–92. [PMC free article] [PubMed]
[13] Smith MA, Liou J-I, Frytak JR, Finch MD. 30-day survival and rehospitalization for stroke patients according to physician specialty. Cerebrovasc Dis. 2006;22:21–6. [PMC free article] [PubMed]
[14] Kaste M, Palomäki H, Sarna S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke. 1995;26:249–53. [PubMed]
[15] Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke: outcomes, patient mix, and practice variation for neurologists and generalists in a community. Neurology. 1998;50:1669–78. [PubMed]
[16] Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke. 1996;27:1937–43. [PubMed]
[17] Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology. 2003;61:792–6. [PubMed]
[18] Selby JV, Fireman BH, Swain BE. Effect of a copayment on use of the emergency department in a health maintenance organization. N Engl J Med. 1996;334:635–41. [PubMed]
[19] Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283–92. [PubMed]
[20] Brown DL, Lisabeth LD, Garcia NM, Smith MA, Morgenstern LB. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project. Neurology. 2004;63:2250–4. [PubMed]
[21] Burgin WS, Staub L, Chan W, et al. Acute stroke care in non-urban emergency departments. Neurology. 2001;57:2006–12. [PubMed]
[22] Mitchell JB, Ballard DJ, Matchar DB, Whisnant JP, Samsa GP. Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists. Health Serv Res. 2000;34:1413–28. [PMC free article] [PubMed]
[23] Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke. 2005;36:374–86. [PubMed]
[24] Johnston SC, Fung LH, Gillum LA, et al. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke. 2001;32:1061–8. [PubMed]
[25] Dávalos A, Castillo J, Martinez-Vila E. Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke. 1995;26:2233–7. [PubMed]
[26] Scott PA, Pancioli AM, Davis LA, Frederiksen SM, Eckman J. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke. 2002;33:2664–9. [PubMed]
[27] Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577–617. [PubMed]
[28] Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2008 [PMC free article] [PubMed]
[29] Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol. 2006;60:301–13. [PubMed]
[30] Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283:3102–9. [PubMed]